Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
15th National Conference of the IAOMFP, Chennai, 2006
Abstract
Abstracts from current literature
Acne in India: Guidelines for management - IAA Consensus Document
Addendum
Announcement
Art & Psychiatry
Article
Articles
Association Activities
Association Notes
Award Article
Book Review
Brief Report
Case Analysis
Case Letter
Case Letters
Case Notes
Case Report
Case Reports
Clinical and Laboratory Investigations
Clinical Article
Clinical Studies
Clinical Study
Commentary
Conference Oration
Conference Summary
Continuing Medical Education
Correspondence
Corrigendum
Cosmetic Dermatology
Cosmetology
Current Best Evidence
Current View
Derma Quest
Dermato Surgery
Dermatopathology
Dermatosurgery Specials
Dispensing Pearl
Do you know?
Drug Dialogues
e-IJDVL
Editor Speaks
Editorial
Editorial Remarks
Editorial Report
Editorial Report - 2007
Editorial report for 2004-2005
Errata
Erratum
Focus
Fourth All India Conference Programme
From Our Book Shelf
From the Desk of Chief Editor
General
Get Set for Net
Get set for the net
Guest Article
Guest Editorial
History
How I Manage?
IADVL Announcement
IADVL Announcements
IJDVL Awards
IJDVL AWARDS 2015
IJDVL Awards 2018
IJDVL Awards 2019
IJDVL Awards 2020
IJDVL International Awards 2018
Images in Clinical Practice
In Memorium
Inaugural Address
Index
Knowledge From World Contemporaries
Leprosy Section
Letter in Response to Previous Publication
Letter to Editor
Letter to the Editor
Letter to the Editor - Case Letter
Letter to the Editor - Letter in Response to Published Article
LETTER TO THE EDITOR - LETTERS IN RESPONSE TO PUBLISHED ARTICLES
Letter to the Editor - Observation Letter
Letter to the Editor - Study Letter
Letter to the Editor - Therapy Letter
Letter to the Editor: Articles in Response to Previously Published Articles
Letters to the Editor
Letters to the Editor - Letter in Response to Previously Published Articles
Letters to the Editor: Case Letters
Letters to the Editor: Letters in Response to Previously Published Articles
Medicolegal Window
Messages
Miscellaneous Letter
Musings
Net Case
Net case report
Net Image
Net Letter
Net Quiz
Net Study
New Preparations
News
News & Views
Obervation Letter
Obituary
Observation Letter
Observation Letters
Oration
Original Article
ORIGINAL CONTRIBUTION
Original Contributions
Pattern of Skin Diseases
Pearls
Pediatric Dermatology
Pediatric Rounds
Perspective
Presedential Address
Presidential Address
Presidents Remarks
Quiz
Recommendations
Regret
Report
Report of chief editor
Report of Hon : Treasurer IADVL
Report of Hon. General Secretary IADVL
Research Methdology
Research Methodology
Resident page
Resident's Page
Resident’s Page
Residents' Corner
Residents' Corner
Residents' Page
Retraction
Review
Review Article
Review Articles
Revision Corner
Self Assessment Programme
SEMINAR
Seminar: Chronic Arsenicosis in India
Seminar: HIV Infection
Short Communication
Short Communications
Short Report
Special Article
Specialty Interface
Studies
Study Letter
Supplement-Photoprotection
Supplement-Psoriasis
Symposium - Contact Dermatitis
Symposium - Lasers
Symposium - Pediatric Dermatoses
Symposium - Psoriasis
Symposium - Vesicobullous Disorders
SYMPOSIUM - VITILIGO
Symposium Aesthetic Surgery
Symposium Dermatopathology
Symposium-Hair Disorders
Symposium-Nails Part I
Symposium-Nails-Part II
Tables
Technology
Therapeutic Guidelines
Therapeutic Guidelines - IADVL
Therapeutics
Therapy
Therapy Letter
View Point
Viewpoint
What’s new in Dermatology
View/Download PDF
Studies
2004:70:5;283-284
PMID: 17642638

Autologous serum skin test in chronic idiopathic urticaria

Kiran V Godse
 Navi Mumbai, India

Correspondence Address:
Kiran V Godse
Shree Skin Centre, 21 & 22, L market, Sector 8, Nerul, Navi Mumbai - 400706
India
How to cite this article:
Godse KV. Autologous serum skin test in chronic idiopathic urticaria. Indian J Dermatol Venereol Leprol 2004;70:283-284
Copyright: (C)2004 Indian Journal of Dermatology, Venereology, and Leprology

Abstract

BACKGROUND AND AIMS: Chronic urticaria has a spectrum of clinical presentations and causes. About 25%-45% of patients have histamine releasing autoantibodies in their blood. The term autoimmune urticaria is increasingly being accepted for this subgroup of patients. The term autoimmune urticaria is used to reflect advances in knowledge about functional autoantibodies that activate mast cells and basophils through cross linking high affinity IgE receptors to secrete histamine. This study was started to find out incidence of autoimmune urticaria in Indian patients. METHODS: The autologous serum skin test was done in 45 patients with chronic urticaria of more than six weeks duration. Physical urticaria patients were not included in the study. RESULTS: Twelve patients had positive autologous serum skin test suggestive of autoimmune urticaria. CONCLUSIONS: Positive autologous serum skin test was seen in 26.67% of patients which is less than reports from Western literature. This is a useful screening test for autoimmune urticaria.
Keywords: Autologous serum skin test, Autoimmune urticaria

INTRODUCTION

Chronic urticaria has a spectrum of clinical presentations and causes. An affected patient often goes from one dermatologist to another for a cure. Despite a dermatologist′s best efforts, no cause can be found in most cases. About 30%-50% of patients with chronic idiopathic urticaria have circulating histamine releasing autoantibodies to the high-affinity IgE receptor Fc RI on basophils and mast cells or, less commonly, antibodies to IgE. The term autoimmune urticaria is increasingly being accepted for this subgroup of patients.

The autologous serum skin test (ASST) is currently the best in vivo clinical test for detection of in vitro basophil histamine-releasing activity.[1] We performed the autologous serum skin test in patients with chronic idiopathic urticaria to determine the incidence of autoimmune urticaria in the Indian population.

METHODS

The study included 45 patients, 20 males and 25 females, in the age group of 15 to 55 years with chronic idiopathic urticaria of more than 6 weeks′ duration. Routine investigations like complete blood count, random blood sugar, urine examination were done to exclude chronic urticaria cases that are not ′idiopathic′. Patients with physical urticaria, and children and pregnant women were not included in the study.

Patients were advised to stop antihistamines and steroids for two days, and doxepin for 3 weeks, before the test. The test was performed by injecting 0.05 ml of the patient′s own serum intradermally into the left flexor forearm 2 inches below the antecubital crease and a saline control into the right forearm. A reading of the wheal was taken after 30 minutes. A wheal and flare of more than 1.5 mm diameter than that of the control was considered positive [Figure - 1].

RESULTS

Out of 45 patients, twelve patients (26.67%) (8 females and 4 males) showed a positive result in the form of a wheal and flare response of more than 1.5 mm than the saline control. All of them had severe disease in the form of recurrent wheals and itching.

DISCUSSION

The basophil histamine release assay is currently the "gold standard" for detecting functional autoantibodies in patients with chronic idiopathic urticaria. However, this bioassay is difficult to standardize because it requires fresh basophils from healthy donors and is time consuming. Western blotting and other nonfunctional assays, including enzyme-linked immunosorbent assay and flow cytometry using chimeric cell lines expressing the human Fc RI , may be useful for screening sera in the future but need to be validated. Hence, ASST is the only practicable test available to clinicians to detect autoimmune urticaria.

In the Western literature, a positive ASST has been reported in 25% to 45% of patients of chronic idiopathic urticaria.[2] The ASST has a sensitivity of 70% and a specificity of 80% when read as a pink serum-induced wheal 1.5 mm or greater than an adjacent normal saline control injection at 30 minutes, although experience is required to obtain reproducible results.[3] A positive test is suggestive but not diagnostic of an autoimmune basis for patient′s urticaria. Confirmation is needed by in vitro testing of the patient′s serum for anti-Fc RI or anti-IgE autoantibodies.[2]

Patients with autoimmune autoantibodies have no distinctive diagnostic clinical features. Autoimmune and non-autoimmune cases are indistinguishable clinically and histologically.[2] However, they do tend to have more severe urticaria.[4] Nettis, et al found ASST can not be used alone either to predict severity of urticaria or to define it as ′autoimmune′.[5] We found the incidence of autoimmune urticaria to be 26.67% which is much lower than reports from Western countries. This test can be done by a dermatologist to determine whether chronic idiopathic urticaria is autoimmune in origin. This is especially important from a management viewpoint since immunosuppressive therapies may be tried if conventional approaches of management are unsuccessful.[1]

References
1.
Grattan CE, Sabroe RA, Greaves MW. Chronic urticaria. J Am Acad Dermatol 2002;46:645-57.
[Google Scholar]
2.
Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000;105:664-72.
[Google Scholar]
3.
Sabroe RA, Grattan CE, Francis DM, Barr RM, Kobza Black A, Greaves MW. The autologous serum skin test: A screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999;140:446-52.
[Google Scholar]
4.
Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-Fc?RI? or anti-IgE autoantibodies. J Am Acad Dermatol 1999;40:443-50.
[Google Scholar]
5.
Nettis E, Dambra P, D'Oronzio L, Cavallo E, Loria MP, Fanelli M, et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 2002;27:29-31.
[Google Scholar]

Fulltext Views
196

PDF downloads
64
Show Sections